Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
Levonorgestrel-releasing intrauterine system treatment of adenomyosis significantly reduced menstrual bleeding, uterine volume, and dysmenorrhea, with anemic patients showing improved hemoglobin levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (11)
- Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis 2021
- Adenomiosis: tratamiento 2015
- Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis 2012
- Mise au point sur l’adénomyose 2012
- Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis 2011
- Hormonal treatments for adenomyosis 2007
- Tratamiento de la adenomiosis 2007
- Traitement de l'adénomyose 2007
- New interventional techniques for adenomyosis 2006
- Adénomyose 2006
- 10.1016/s0246-1064(14)65366-4 2000
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00